Navigation Links
Former Johnson & Johnson Executive Gives Big Voice to Small Companies
Date:1/15/2009

Big Pharma Perspective Gives Edge to Private Firms

PHILADELPHIA, Jan. 15 /PRNewswire/ -- Michael Parks, former Vice President of Corporate Communications for Centocor, Inc., an operating company of Johnson & Johnson (J&J) today announced the launch of a public relations consultancy, Pitch360 Incorporated (www.pitch360inc.com). Pitch360 is a public relations, marketing communications, and issues management consultancy that leverages its vast pharmaceutical and biotechnology experience to transform the way companies communicate to their customers, key stakeholders, and mainstream and social media.

"After nearly 15 years serving the pharma industry and growing from that experience, I wanted to design a consultancy that specifically caters to the next generation of companies that promise breakthrough therapies for patients," said Michael Parks, Founder and President of Pitch360 Inc. "In particular, small companies can now bypass the trial-and-error process of their predecessors and immediately put breakthrough strategies to work for their business."

Created with the changing needs of the industry in mind, Pitch360 uses its relationships with a wide variety of stakeholders in the pharmaceutical and biotech industry to stay ahead of 'status quo' thinking so that they can bring forward ideas that rise above that of their competition. Through well established networks of healthcare providers, experts in government, regulatory and policy matters; creative media talent, as well the healthcare, business, mainstream and social media; Pitch360 has the tools and experience necessary to provide breakthrough strategies that companies can implement to deliver on their business objectives.

"In today's economy, companies are looking for value and innovation," said Mr. Parks. "Pitch360 provides affordable communications solutions using breakthrough strategies that will deliver outstanding results."

Pitch360 has a wide variety of services available for companies and not-for-profit groups, including strategic counseling, issues management, and investor relations and delivers these services with outstanding customer service and support. Pitch360 provides specialty services for companies of all sizes.

ABOUT THE FOUNDER

Prior to founding Pitch360 in 2008, Michael Parks was the Vice President of Corporate Communications at Centocor, Inc., an operating company of Johnson & Johnson. In this role, he acted as the company's Chief Communications Officer with communications responsibility for the protection and enhancement of the company's image and products from a commercial, research & development, and manufacturing perspective. Prior to that, Michael held executive positions at Pharmacia Corporation and Searle Pharmaceuticals, and led efforts related to the launch of a number of blockbuster products. Michael has been a pioneer in social media for the pharma industry and was also the Executive Producer of the groundbreaking documentary, INNERSTATE, a film that chronicled the devastating impact of chronic disease and the promise of innovation. This documentary was a first for the pharmaceutical industry and just part of Michael's broad portfolio of innovative approaches to effectively communicating complex issues to a wide variety of audiences.


'/>"/>
SOURCE Pitch360 Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board
2. Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
3. VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board
4. LCA-Visions Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
5. Comment of Senator Patrick Leahy (D-Vt.) on President-elect Obamas Choice of Former Senator Tom Daschle to Head The Department of Health and Human Services and A New White House Office of Health Reform
6. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill
7. Former Mayor of Indianapolis to Serve as a Senior Strategic Advisor to McKenna Long & Aldridge LLPs Global Infrastructure Finance and Public-Private Partnerships Practice
8. Sweet Surprise: Even Former Critics Dispel Long-Held Myths About High Fructose Corn Syrup
9. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
10. TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries
11. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... FL (PRWEB) , ... May 06, 2016 , ... ... will feature AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery ... the vision of becoming a leader in optimized drug discovery through innovative cellular ...
(Date:5/6/2016)... ... , ... Online HR/benefits platforms offer a range of benefits functions to employers ... health plans. “ The Rapid Emergence of Online Benefits Firms: Strategies for Health Plans ... will offer an accurate picture of online benefits today, and the possible risks and ...
(Date:5/6/2016)... ... 06, 2016 , ... Canadian author Mark Black is a speaker, author, and life ... around the world … with the help of his publisher Strategic Book Group and its ... in a hospital bed waiting for a miracle: He needed a heart and double-lung transplant. ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning ... and operated for over 35 years. Maintaining core values of exceptional customer service, quality ... and made them a leading name in San Diego plumbing, and other services including ...
(Date:5/6/2016)... ... May 06, 2016 , ... In honor of Military ... corporate training, and the National Military Family Association, a nonprofit that works to ... second full-tuition scholarship recipient of 2016. , “Being awarded this scholarship by ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Israel , May 4, 2016 ... BiondVax,s CEO, Dr. Ron Babecoff , will be attending ... York City . On Thursday, May 5, ... a conference presented by Joseph Gunner & Co, ... The BiondVax presentation that Dr. Babecoff will be using is ...
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... completion of an alternative public offering (APO). This was ... operating company, Valeritas, Inc. and a private placement of ... at $5.00 per share. Under the terms ... 3, 2016, Valeritas Holdings, Inc. will trade on the ...
Breaking Medicine Technology: